黑色素瘤与皮肤癌的进展
Advances in Melanoma and Skin Cancers.
作者信息
Mallardo Domenico, Basile Debora, Vitale Maria Grazia
机构信息
Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Via Mariano Semmola, 53, 80131 Naples, Italy.
Unit of Medical Oncology, Ospedale San Giovanni di Dio, 88900 Crotone, Italy.
出版信息
Int J Mol Sci. 2025 Feb 21;26(5):1849. doi: 10.3390/ijms26051849.
Abstract
Cutaneous melanoma, with a continuously rising incidence worldwide, represents one of the most aggressive forms of skin cancer [...].
摘要
皮肤黑色素瘤在全球范围内的发病率持续上升，是最具侵袭性的皮肤癌形式之一[...]。
相似文献
1
Advances in Melanoma and Skin Cancers.黑色素瘤与皮肤癌的进展
Int J Mol Sci. 2025 Feb 21;26(5):1849. doi: 10.3390/ijms26051849.
2
[Cutaneous melanoma: from rationalized models to patients care].[皮肤黑色素瘤：从合理模型到患者护理]
Med Sci (Paris). 2018 May;34(5):407-416. doi: 10.1051/medsci/20183405013. Epub 2018 Jun 13.
3
Cutaneous Melanoma-A Long Road from Experimental Models to Clinical Outcome: A Review.皮肤黑色素瘤——从实验模型到临床结果的漫长道路：综述。
Int J Mol Sci. 2018 May 24;19(6):1566. doi: 10.3390/ijms19061566.
4
Cutaneous malignant melanoma.皮肤恶性黑色素瘤
Bol Asoc Med P R. 1984 May;76(5):210-5.
5
The sun's evil enterprise. Malignant melanoma.太阳的邪恶产物。恶性黑色素瘤。
Adv Nurse Pract. 2008 Feb;16(2):69-70, 72-4.
6
Cutaneous melanoma: From pathogenesis to therapy (Review).皮肤黑色素瘤：从发病机制到治疗（综述）。
Int J Oncol. 2018 Apr;52(4):1071-1080. doi: 10.3892/ijo.2018.4287. Epub 2018 Feb 27.
7
A new era in melanoma.黑色素瘤的新时代。
Dermatol Ther. 2012 Sep-Oct;25(5):389-91. doi: 10.1111/j.1529-8019.2012.01529.x.
8
CRC-BACR-AICR International Workshop. Melanogenesis: its chemistry as a therapeutic strategy in melanoma.结直肠癌-遗传性非息肉病性结直肠癌-美国癌症研究协会国际研讨会。黑色素生成：其化学性质作为黑色素瘤的一种治疗策略。
Br J Cancer. 1991 Oct;64(4):793-5. doi: 10.1038/bjc.1991.401.
9
Tetraspanin8 expression predicts an increased metastatic risk and is associated with cancer-related death in human cutaneous melanoma.四跨膜蛋白8的表达预示着人类皮肤黑色素瘤转移风险增加，并与癌症相关死亡有关。
Mol Cancer. 2021 Oct 2;20(1):127. doi: 10.1186/s12943-021-01429-0.
10
Skin diseases with high public health impact. Melanoma.对公众健康有重大影响的皮肤病。黑色素瘤。
Eur J Dermatol. 2007 Nov-Dec;17(6):559-62. doi: 10.1684/ejd.2007.0291. Epub 2007 Oct 19.
引用本文的文献
1
Dual targeting of VEGFR2 and CSF1R with SYHA1813 confers novel strategy for treating both BRAF wild-type and mutant melanoma.SYHA1813对VEGFR2和CSF1R的双重靶向作用为治疗BRAF野生型和突变型黑色素瘤提供了新策略。
Cancer Cell Int. 2025 Jul 25;25(1):281. doi: 10.1186/s12935-025-03902-y.
2
Direct effects of the small molecule PD‑L1 inhibitor BMS‑202 on A375 melanoma cells: Anti‑tumor activity accompanied by increased mitochondrial function.小分子PD-L1抑制剂BMS-202对A375黑色素瘤细胞的直接作用：抗肿瘤活性伴随着线粒体功能增强。
Mol Med Rep. 2025 Sep;32(3). doi: 10.3892/mmr.2025.13607. Epub 2025 Jul 11.
3
Quercetin as a Potential Therapeutic Agent for Malignant Melanoma-A Review of Current Evidence and Future Directions.槲皮素作为恶性黑色素瘤的潜在治疗药物——当前证据与未来方向综述
Medicina (Kaunas). 2025 Apr 2;61(4):656. doi: 10.3390/medicina61040656.
本文引用的文献
1
A Combined Proteomic and Transcriptomic Signature Is Predictive of Response to Anti-PD-1 Treatment: A Retrospective Study in Metastatic Melanoma Patients.联合蛋白质组学和转录组学特征可预测抗 PD-1 治疗的反应：转移性黑色素瘤患者的回顾性研究。
Int J Mol Sci. 2024 Aug 28;25(17):9345. doi: 10.3390/ijms25179345.
2
Recent advances in immunotherapy and its combination therapies for advanced melanoma: a review.晚期黑色素瘤免疫疗法及其联合疗法的最新进展：综述
Front Oncol. 2024 Jul 16;14:1400193. doi: 10.3389/fonc.2024.1400193. eCollection 2024.
3
Novel liquid biopsy CNV biomarkers in malignant melanoma.恶性黑色素瘤新型液体活检 CNV 生物标志物。
Sci Rep. 2024 Jul 9;14(1):15786. doi: 10.1038/s41598-024-65928-y.
4
Pentoxifylline and Norcantharidin Modify p62 Expression in 2D and 3D Cultures of B16F1 Cells.己酮可可碱和去甲斑蝥素改变 B16F1 细胞 2D 和 3D 培养物中 p62 的表达。
Int J Mol Sci. 2024 May 9;25(10):5140. doi: 10.3390/ijms25105140.
5
Strategic approaches in oral squamous cell carcinoma diagnostics using liquid biopsy.液体活检在口腔鳞状细胞癌诊断中的策略方法。
Periodontol 2000. 2024 Oct;96(1):316-328. doi: 10.1111/prd.12567. Epub 2024 Apr 27.
6
Anti-Melanoma Effects of Miconazole: Investigating the Mitochondria Involvement.咪康唑的抗黑色素瘤作用：探究线粒体的参与。
Int J Mol Sci. 2024 Mar 22;25(7):3589. doi: 10.3390/ijms25073589.
7
Effective Targeting of Melanoma Cells by Combination of Mcl-1 and Bcl-2/Bcl-x/Bcl-w Inhibitors.联合 Mcl-1 和 Bcl-2/Bcl-x/Bcl-w 抑制剂靶向黑色素瘤细胞。
Int J Mol Sci. 2024 Mar 19;25(6):3453. doi: 10.3390/ijms25063453.
8
Programmed Cell Death Ligand 1 Immunohistochemical Expression and Cutaneous Melanoma: A Controversial Relationship.程序性细胞死亡配体 1 的免疫组织化学表达与皮肤黑色素瘤：一种有争议的关系。
Int J Mol Sci. 2024 Jan 4;25(1):676. doi: 10.3390/ijms25010676.
9
Current Status and Molecular Mechanisms of Resistance to Immunotherapy in Oral Malignant Melanoma.口腔恶性黑色素瘤的免疫治疗耐药现状及分子机制。
Int J Mol Sci. 2023 Dec 8;24(24):17282. doi: 10.3390/ijms242417282.
10
In Vitro Experiments on the Effects of GP-2250 on BRAF-Mutated Melanoma Cell Lines and Benign Melanocytes.体外实验研究 GP-2250 对 BRAF 突变型黑素瘤细胞系和良性黑素细胞的影响。
Int J Mol Sci. 2023 Oct 19;24(20):15336. doi: 10.3390/ijms242015336.
Zotero 插件